miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1

Siegel, 2012, Cancer treatment and survivorship statistics, 2012, CA Cancer J Clin, 62, 220, 10.3322/caac.21149

Sturge, 2011, Bone metastasis in prostate cancer: Emerging therapeutic strategies, Nat Rev Clin Oncol, 8, 357, 10.1038/nrclinonc.2011.67

Maugeri-Sacca, 2012, MicroRNAs and prostate cancer: From preclinical research to translational oncology, Cancer J, 18, 253, 10.1097/PPO.0b013e318258b5b6

Fang, 2013, Roles of microRNAs during prostatic tumorigenesis and tumor progression, Oncogene

Kim, 2013, MicroRNAs in prostate cancer, Prostate Int, 1, 3, 10.12954/PI.12011

Taganov, 2006, NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc Natl Acad Sci U S A, 103, 12481, 10.1073/pnas.0605298103

Perry, 2008, Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells, J Immunol, 180, 5689, 10.4049/jimmunol.180.8.5689

Chen, 2013, miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells, PLoS One, 8, e60317, 10.1371/journal.pone.0060317

Kogo, 2011, Clinical significance of miR-146a in gastric cancer cases, Clin Cancer Res, 17, 4277, 10.1158/1078-0432.CCR-10-2866

Li, 2010, miR-146a suppresses invasion of pancreatic cancer cells, Cancer Res, 70, 1486, 10.1158/0008-5472.CAN-09-2792

Lin, 2008, Loss of mir-146a function in hormone-refractory prostate cancer, RNA, 14, 417, 10.1261/rna.874808

Yao, 2013, MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2, Cancer Lett, 335, 219, 10.1016/j.canlet.2013.02.031

Bae, 1994, Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression, Int J Cancer, 58, 721, 10.1002/ijc.2910580517

Liu, 2013, MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumor cells, Cell Death Dis, 4, e928, 10.1038/cddis.2013.458

Bae, 1998, Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line, Prostate, 34, 275, 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G

Liu, 2012, Identification of microRNA transcriptome involved in human natural killer cell activation, Immunol Lett, 143, 208, 10.1016/j.imlet.2012.02.014

Huang, 2012, SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane, Nat Commun, 3, 911, 10.1038/ncomms1919

Limame, 2012, Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays, PLoS One, 7, e46536, 10.1371/journal.pone.0046536

He, 2005, The role of microRNA genes in papillary thyroid carcinoma, Proc Natl Acad Sci U S A, 102, 19075, 10.1073/pnas.0509603102

Wang, 2008, Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth, PLoS One, 3, e2557, 10.1371/journal.pone.0002557

Wang, 2008, The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer, J Biol Chem, 283, 4283, 10.1074/jbc.M707465200

Schnelzer, 2000, Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b, Oncogene, 19, 3013, 10.1038/sj.onc.1203621

Pan, 2004, Expression of seven main Rho family members in gastric carcinoma, Biochem Biophys Res Commun, 315, 686, 10.1016/j.bbrc.2004.01.108

Kamai, 2004, Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer, Clin Cancer Res, 10, 4799, 10.1158/1078-0432.CCR-0436-03

Engers, 2007, Prognostic relevance of increased Rac GTPase expression in prostate carcinomas, Endocr Relat Cancer, 14, 245, 10.1677/ERC-06-0036